tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Vanda Pharmaceuticals: Strong Financial Performance and Strategic Growth Justify Buy Rating
PremiumRatingsVanda Pharmaceuticals: Strong Financial Performance and Strategic Growth Justify Buy Rating
2M ago
Vanda Pharmaceuticals’ Earnings Call: Growth Amid Challenges
Premium
Company Announcements
Vanda Pharmaceuticals’ Earnings Call: Growth Amid Challenges
3M ago
Vanda Pharmaceuticals Reports Q1 2025 Financial Results
Premium
Company Announcements
Vanda Pharmaceuticals Reports Q1 2025 Financial Results
3M ago
Vanda Pharmaceuticals: Strategic Advancements and Financial Strength Underpin Buy Rating
PremiumRatingsVanda Pharmaceuticals: Strategic Advancements and Financial Strength Underpin Buy Rating
4M ago
Vanda Pharmaceuticals submits NDA to FDA for Bysanti
Premium
The Fly
Vanda Pharmaceuticals submits NDA to FDA for Bysanti
4M ago
Positive Outlook for Vanda Pharmaceuticals: FDA Acceptance and Strong Financial Position Bolster Buy Rating
Premium
Ratings
Positive Outlook for Vanda Pharmaceuticals: FDA Acceptance and Strong Financial Position Bolster Buy Rating
4M ago
Vanda Pharmaceuticals’ Earnings Call: Mixed Results and Future Optimism
PremiumCompany AnnouncementsVanda Pharmaceuticals’ Earnings Call: Mixed Results and Future Optimism
5M ago
Vanda Pharmaceuticals Sees Revenue Growth Amid Strategic Expansions
Premium
Company Announcements
Vanda Pharmaceuticals Sees Revenue Growth Amid Strategic Expansions
5M ago
Vanda Pharmaceuticals sees FY25 revenue $210M-$250M, consensus $284.9M
Premium
The Fly
Vanda Pharmaceuticals sees FY25 revenue $210M-$250M, consensus $284.9M
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100